Maximal medical therapy for chronic rhinosinusitis

Valerie J Lund

doi:10.1016/j.otc.2005.07.003

Maximal medical therapy for chronic rhinosinusitis

Otolaryngol Clin North Am. 2005 Dec;38(6):1301-10, x. doi: 10.1016/j.otc.2005.07.003.

Author

Valerie J Lund¹

Affiliation

¹ The Ear Institute, University College London, 330 Gray's Inn Road, London WC1X 8DA, UK. v.lund@ucl.ac.uk

PMID: 16326186
DOI: 10.1016/j.otc.2005.07.003

Abstract

Chronic rhinosinusitis (CRS) is widely recognized as one of the most common, if not the most common, chronic disease entities. This article discusses CRS without nasal polyposis. The discussion of maximal medical therapy concentrates on the best available evidence from published clinical trials.

Publication types

Review

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Anti-Bacterial Agents / therapeutic use
Antifungal Agents / therapeutic use
Chronic Disease
Humans
Rhinitis / drug therapy*
Sinusitis / drug therapy*

Substances

Adrenal Cortex Hormones
Anti-Bacterial Agents
Antifungal Agents